Too little, too late: ineffective regulation of dietary supplements in the United States
- PMID: 25602879
- PMCID: PMC4330859
- DOI: 10.2105/AJPH.2014.302348
Too little, too late: ineffective regulation of dietary supplements in the United States
Abstract
Millions of people in the United States consume dietary supplements hoping to maintain or improve their health; however, extensive research has failed to demonstrate the efficacy of numerous supplements in disease prevention. In addition, concerns about the safety of routine and high-dose supplementation have been raised. The Food and Drug Administration regulates dietary supplement quality, safety, and labeling, and the Federal Trade Commission monitors advertisements and marketing; still, vast enforcement challenges remain, and optimal governmental oversight has not been achieved. If the composition and quality of ingredients cannot be reliably ensured, the validity of research on dietary supplements is questionable. Moreover, the health of the US public is put at risk.
Comment in
-
Starr Responds.Am J Public Health. 2015 Jul;105(7):e3-4. doi: 10.2105/AJPH.2015.302754. Epub 2015 May 14. Am J Public Health. 2015. PMID: 25973821 Free PMC article. No abstract available.
-
Regarding the Regulation of Dietary Supplements.Am J Public Health. 2015 Jul;105(7):e3. doi: 10.2105/AJPH.2015.302708. Epub 2015 May 14. Am J Public Health. 2015. PMID: 25973824 Free PMC article. No abstract available.
References
-
- Dietary Supplement Health and Education Act of 1994, Pub L 103–417, 108 Stat. 4325.
-
- US Government Accountability Office. Dietary Supplements: FDA Should Take Further Actions to Improve Oversight and Consumer Understanding. Washington, DC: US Government Accountability Office; 2009. pp. GAO-09–GAO-250.
-
- Natural Medicines Comprehensive Database. About Natural Medicines Comprehensive Database. Available at: http://naturaldatabase.therapeuticresearch.com/Content.aspx?cs=&s=ND&pag.... Accessed August 15, 2014.
-
- US Government Accountability Office. Dietary Supplements—FDA May Have Opportunities to Expand Its Use of Reported Health Problems to Oversee Products. Washington, DC: US Government Accountability Office; 2013. pp. 13–244.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical